| Preclinical assessment of β-d-mannuronic acid (M2000) as a non-steroidal anti-inflammatory drug MJ Fattahi, M Abdollahi, A Agha Mohammadi, N Rastkari, R Khorasani, ... Immunopharmacology and immunotoxicology 37 (6), 535-540, 2015 | 69 | 2015 |
| ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer S Nouruzi, D Ganguli, N Tabrizian, M Kobelev, O Sivak, T Namekawa, ... Nature Communications 13 (1), 2282, 2022 | 63 | 2022 |
| Therapeutic effects of D-aspartate in a mouse model of multiple sclerosis S Afraei, A D'Aniello, R Sedaghat, P Ekhtiari, G Azizi, N Tabrizian, ... journal of food and drug analysis 25 (3), 699-708, 2017 | 21 | 2017 |
| Efficacy and safety of G2013 as a novel immunosuppressive agent on differentiation, maturation and function of human dendritic cells NA Fard, N Tabrizian, R Mirzaei, J Hadjati, FT Zavareh, ARS Nodeh, ... Iranian Journal of Public Health 46 (2), 216, 2017 | 12 | 2017 |
| The biology of β-D-mannuronic acid (M2000) on human dendritic cell based on MicroRNA-155 and MicroRNA-221 N Tabrizian, N Arjomand Fard, A Farazmand, R Eftekhari, ... Current Drug Discovery Technologies 14 (1), 53-58, 2017 | 4 | 2017 |
| The safety property of β-D-Mannuronic acid (M2000) as a novel immunosuppressive agent on differentiation, maturation and function of human dendritic cells N A Fard, N Tabrizian, R Mirzaei, N Motamed, F T Zavareh, A Mirshafiey Current Drug Discovery Technologies 13 (3), 164-169, 2016 | 4 | 2016 |
| ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer N Tabrizian, S Nouruzi, CJ Cui, M Kobelev, T Namekawa, I Lodhia, ... Cell Reports 42 (8), 2023 | 3 | 2023 |
| Beyond expression: role of phosphorylated residues of EZH2 in lineage plasticity in prostate cancer S Nouruzi, N Tabrizian, A Zoubeidi Endocrinology 164 (4), bqad023, 2023 | 2 | 2023 |
| Targeting adenocarcinoma and enzalutamide‑resistant prostate cancer using the novel anti‑androgen inhibitor ADA‑308 S Nouruzi, F Johnson, S Kumar, O Sivak, N Tabrizian, M Koistinaho, ... Oncology Reports 52 (4), 132, 2024 | | 2024 |
| ASCL1 activates neuronal stem cell-like lineage programming through the remodeling of the chromatin landscape in prostate cancer S Nouruzi, D Ganguli, N Tabrizian, M Kobelev, O Sivak, T Namekawa, ... Cancer Research 83 (7_Supplement), 4730-4730, 2023 | | 2023 |
| Signaling pathways: the driving force behind lineage plasticity in treatment resistance prostate cancer N Tabrizian University of British Columbia, 2023 | | 2023 |
